Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.740
+0.080 (4.82%)
At close: Nov 28, 2025, 1:00 PM EST
1.672
-0.068 (-3.93%)
After-hours: Nov 28, 2025, 4:16 PM EST

Artelo Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20212016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
Net Income
-12.49-9.83-9.29-10.08-12.11-7.44
Upgrade
Other Amortization
0.14-----
Upgrade
Loss (Gain) From Sale of Investments
-0.03-0.28-0.64-0.21-0.020
Upgrade
Stock-Based Compensation
0.980.821.022.462.81.53
Upgrade
Other Operating Activities
-0.040.030.040.040.030.01
Upgrade
Change in Accounts Payable
3.220.480.270.021.5-0
Upgrade
Change in Other Net Operating Assets
0.060.430.39-0.24-0.21-0.24
Upgrade
Operating Cash Flow
-8.18-8.35-8.21-8.01-8-6.14
Upgrade
Investment in Securities
0.57.773.512.96-30.1-3.44
Upgrade
Investing Cash Flow
0.257.773.512.96-30.1-3.44
Upgrade
Short-Term Debt Issued
-----0
Upgrade
Total Debt Issued
0.74----0
Upgrade
Short-Term Debt Repaid
------0.01
Upgrade
Total Debt Repaid
-----0-0.01
Upgrade
Net Debt Issued (Repaid)
0.74----0-0.01
Upgrade
Issuance of Common Stock
4.580.110.57-54.7914.12
Upgrade
Financing Cash Flow
5.320.110.57-54.7814.11
Upgrade
Foreign Exchange Rate Adjustments
-0.03-0.010.06-0.22-0.08-0.05
Upgrade
Net Cash Flow
-2.64-0.48-4.07-5.2716.64.49
Upgrade
Free Cash Flow
-8.18-8.35-8.21-8.01-8-6.14
Upgrade
Free Cash Flow Per Share
-12.41-15.54-16.64-16.96-21.53-29.59
Upgrade
Levered Free Cash Flow
-3.47-4.7-4.64-4.31--3.18
Upgrade
Unlevered Free Cash Flow
-3.49-4.7-4.64-4.3--3.18
Upgrade
Change in Working Capital
3.280.910.66-0.221.29-0.24
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q